KD

Active Director Director DIN 06836911
DIN 06836911 First appointment Jul 2014 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2014
Shareholding value •••• Premium profile

About Kapil Dev

Data last updated:

Kapil Dev is a Director at Vetcure Pharmaceuticals Private Limited (since 2014). The company operates in Chemicals. Vetcure Pharmaceuticals Private Limited reported revenue of ₹1,010 (FY 2025).

DIN 06836911
Primary Designation Director
Industry Chemicals
First Appointment 17 Jul 2014
Oldest Company Age 12 yrs
Largest company Vetcure Pharmaceuticals Private Limited · ₹1,010 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Jul 20142014₹1,010 (FY 2025)Active

Board colleagues of Kapil Dev

NameDINCompanyDesignation
Rinki Sharma06836917Vetcure Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Vetcure Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Kapil Dev

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kapil Dev

Kapil Dev currently holds 1 directorship: Vetcure Pharmaceuticals Private Limited (Director, since 17 Jul 2014, revenue ₹1,010 (FY 2025)).

Kapil Dev was first appointed on 17 Jul 2014 as Director at Vetcure Pharmaceuticals Private Limited.

The current boards of Kapil Dev's companies include Rinki Sharma (Vetcure Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available